Solventum Corp (SOLV): Net Income

Annual figures by period end, from SEC filings.

$1.56B

Year ended 2025-12-31

$1.43B

Trailing 12 months to 2026-06-30

+5.0%

3-year compound annual growth

2022-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	$1.56B	+224.8%	2026-02-27, From 2025-01-01
2024-12-31	$479.00M	-64.4%	2026-02-27, From 2024-01-01
2023-12-31	$1.35B	+0.2%	2026-02-27, From 2023-01-01
2022-12-31	$1.34B	n/a	2025-02-28, From 2022-01-01

Net Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Solventum Corp (SOLV)	2025-12-31	$1.56B	+224.8%
Baxter International Inc (BAX)	2025-12-31	-$957.00M	n/m
ResMed Inc (RMD)	2026-06-30	$1.52B	+8.8%
Dexcom Inc (DXCM)	2025-12-31	$836.30M	+45.1%
Boston Scientific Corp (BSX)	2025-12-31	$2.89B	+56.7%
Becton Dickinson & Co (BDX)	2025-09-30	$1.68B	-1.6%
MiniMed Group, Inc. (MMED)	2026-04-24	-$333.00M	n/m
West Pharmaceutical Services Inc (WST)	2025-12-31	$493.70M	+0.2%
Globus Medical Inc (GMED)	2025-12-31	$537.87M	+422.3%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗